Testbiotech demands major revision
11 May 2020 / The European Food Safety Authority (EFSA) is holding a public consultation on plants developed with new methods of genetic engineering (genome editing). The EFSA draft document looks at changes made to the genome using tools such as CRISPR/Cas, but without the insertion of additional gene sequences. Testbiotech has concluded that the published draft suffers extensively from not taking numerous relevant publications and important scientific findings into account.
EU Commission wants to promote cooperation with Trump Administration on biotechnology
7 May 2020 / In a letter to Testbiotech, the EU Commission rejected the concerns regarding a new trade deal with the US. In this context, Testbiotech is warning that the approval process for genetically engineered plants will be accelerated and the standards for risk assessment lowered. According to the letter from the EU Commission, there are no plans to change the legal standards.
Testbiotech demands that ‘cut-off’ criteria are applied
30 April 2020 / The European Food Safety Authority (EFSA) carried out a public consultation on guidance for the risk assessment of so-called gene drives at the request of the EU Commission. At the same time, a new Testbiotech scientific paper was accepted after peer review. The paper shows that the EFSA concept is insufficient. To control the risks of gene drives, ‘cut-off criteria’ need to be defined to prevent the uncontrolled spread of genetically engineered organisms.
New publication on technology assessment of gene drives
27 April 2020 / The GeneTip research project was a joint enterprise carried out from 2017 until 2019 by the Universities of Bremen and Vechta, the University of Natural Resources and Life Sciences, Vienna and Testbiotech, Munich. The researchers focused on risks associated with the spread of newly designed genetically engineered organisms into the environment. In particular, the project examined plants and animals with a so-called gene drive. The results have now been published in full by the Springer Publishing Company in a book titled “Gene Drives at Tipping Points“ (open access).